These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24924765)

  • 1. Transgenic mouse technology in skin biology: inducible gene knockout in mice.
    Günschmann C; Chiticariu E; Garg B; Hiz MM; Mostmans Y; Wehner M; Scharfenberger L
    J Invest Dermatol; 2014 Jul; 134(7):1-4. PubMed ID: 24924765
    [No Abstract]   [Full Text] [Related]  

  • 2. Inducible Cre mice.
    Feil S; Valtcheva N; Feil R
    Methods Mol Biol; 2009; 530():343-63. PubMed ID: 19266339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mouse technology in skin biology: generation of complete or tissue-specific knockout mice.
    Scharfenberger L; Hennerici T; Király G; Kitzmüller S; Vernooij M; Zielinski JG
    J Invest Dermatol; 2014 Jan; 134(1):1-5. PubMed ID: 24352082
    [No Abstract]   [Full Text] [Related]  

  • 4. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.
    Andersson KB; Winer LH; Mørk HK; Molkentin JD; Jaisser F
    Transgenic Res; 2010 Aug; 19(4):715-25. PubMed ID: 19894134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele.
    Korecki AJ; Hickmott JW; Lam SL; Dreolini L; Mathelier A; Baker O; Kuehne C; Bonaguro RJ; Smith J; Tan CV; Zhou M; Goldowitz D; Deussing JM; Stewart AF; Wasserman WW; Holt RA; Simpson EM
    Genetics; 2019 Apr; 211(4):1155-1177. PubMed ID: 30765420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice.
    Zhong ZA; Sun W; Chen H; Zhang H; Lay YE; Lane NE; Yao W
    Bone; 2015 Dec; 81():614-619. PubMed ID: 26232373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a tamoxifen inducible Tnnt2MerCreMer knock-in mouse model for cardiac studies.
    Yan J; Sultana N; Zhang L; Park DS; Shekhar A; Hu J; Bu L; Cai CL
    Genesis; 2015 Jun; 53(6):377-86. PubMed ID: 26010701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Cre recombinase alone can induce complete tumor regression.
    Li Y; Choi PS; Casey SC; Felsher DW
    PLoS One; 2014; 9(9):e107589. PubMed ID: 25208064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in inducible expression in transgenic mice.
    Albanese C; Hulit J; Sakamaki T; Pestell RG
    Semin Cell Dev Biol; 2002 Apr; 13(2):129-41. PubMed ID: 12240598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.
    Lou DQ; Molina T; Bennoun M; Porteu A; Briand P; Joulin V; Vasseur-Cognet M; Cavard C
    Cancer Lett; 2005 Nov; 229(1):107-14. PubMed ID: 16157222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse technology in skin biology: generation of knockin mice.
    Tellkamp F; Benhadou F; Bremer J; Gnarra M; Knüver J; Schaffenrath S; Vorhagen S
    J Invest Dermatol; 2014 Dec; 134(12):1-3. PubMed ID: 25381772
    [No Abstract]   [Full Text] [Related]  

  • 15. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage.
    Henry SP; Jang CW; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B
    Genesis; 2009 Dec; 47(12):805-14. PubMed ID: 19830818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generating Beta-Cell-Specific Transgenic Mice Using the Cre-Lox System.
    Smith LIF; Hill TG; Bowe JE
    Methods Mol Biol; 2020; 2128():181-205. PubMed ID: 32180194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of transgenic mice expressing tamoxifen-inducible cre-fusion protein specifically in mouse liver.
    Zhu HZ; Chen JQ; Cheng GX; Xue JL
    World J Gastroenterol; 2003 Aug; 9(8):1844-7. PubMed ID: 12918135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporally and spatially controllable gene expression and knockout in mouse urothelium.
    Zhou H; Liu Y; He F; Mo L; Sun TT; Wu XR
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F387-95. PubMed ID: 20427471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.